Skip to content Skip to search Skip to footer
Washington University School of Medicine in St. Louis

Department of Neurology

ALS Center

Menu
  • Home
  • About
    • About the ALS Center
    • Meet the Team
    • Our Story
    • Diversity, Equity, and Inclusion
  • Patient Care
    • Patient Care Services
    • Schedule Appointment
    • Education & Resources
    • Testimonial Videos
  • Clinical Trials
    • Clinical Trials & Studies
    • WashU Clinical Trials
    • National Clinical Trials
  • Miller Lab
  • News
    • News
    • ALS Center Newsletters
    • Publications
  • Donate
  • Contact

Category: Media

Experimental drug shows promising results for rare form of ALS (Links to an external site)

July 9, 2020September 18, 2020

Researchers led by a Washington University neurologist found promising results for an experimental drug to treat a rare, inherited form of amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease.

Research in St. Louis leads to promise in the fight against ALS (Links to an external site)

July 9, 2020September 18, 2020

ST. LOUIS – Research taking place at Washington University’s School of Medicine is giving hope to those affected by amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.

ALS Center

Department of Neurology

Washington University School of Medicine

660 S. Euclid Ave., CB 8111

St. Louis, MO 63110

  • Twitter

Stay Connected

Join our email list to receive newsletters
and updates from the ALS Center.

Sign Up Now

To learn more about our translational research visit the Miller Lab website.

Make A Difference

Your thoughtful contribution enables us to continue researching possible treatments and ultimately cures for this devastating disease.

Donate

©2023 Washington University in St. Louis